Brainsway Stock

Brainsway ROCE 2024

Brainsway ROCE

-0.12

Ticker

BWAY.TA

ISIN

IL0011007189

WKN

A0NDVW

In 2024, Brainsway's return on capital employed (ROCE) was -0.12, a -57.3% increase from the -0.28 ROCE in the previous year.

Brainsway Aktienanalyse

What does Brainsway do?

Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Brainsway's Return on Capital Employed (ROCE)

Brainsway's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Brainsway's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Brainsway's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Brainsway’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Brainsway stock

What is the ROCE (Return on Capital Employed) of Brainsway this year?

The ROCE of Brainsway is -0.12 undefined this year.

How has the ROCE (Return on Capital Employed) of Brainsway developed compared to the previous year?

The ROCE of Brainsway has increased by -57.3% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Brainsway?

A high Return on Capital Employed (ROCE) indicates that Brainsway has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Brainsway?

A low ROCE (Return on Capital Employed) can indicate that Brainsway has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Brainsway impact the company?

An increase in the ROCE of Brainsway can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Brainsway affect the company?

A decrease in ROCE of Brainsway can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Brainsway?

Some factors that can affect Brainsway's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Brainsway so important for investors?

The ROCE of Brainsway is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Brainsway take to improve the ROCE?

To improve the ROCE, Brainsway can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Brainsway pay?

Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.

What is the dividend yield of Brainsway?

The current dividend yield of Brainsway is .

When does Brainsway pay dividends?

Brainsway pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Brainsway?

Brainsway paid dividends every year for the past 0 years.

What is the dividend of Brainsway?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Brainsway located?

Brainsway is assigned to the 'Health' sector.

Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Brainsway from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Brainsway pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Brainsway in the year 2023?

In the year 2023, Brainsway distributed 0 USD as dividends.

In which currency does Brainsway pay out the dividend?

The dividends of Brainsway are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Brainsway

Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.